Dendreon (DNDN) Shares Rise After Approval of Provenge

Dendreon Corp's Provenge Approval Means Share Prices Rise Provenge is the new prostate cancer treatment that is being called 'one-of-a-kind' that actually uses the body's own immune system to fight the cancer. It is...

Prostate Cancer History Was Made Today!

A non toxic, non invasive Immunotherapy to strengthen the body’s ability to fight prostate cancer achieved its goal of being  supportive of the previous trials, as required by the FDA. Mitchell Gold,...